Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S100A4 | P26447 | 1/20 | 0.41 |
| ▸ | PTPRC | P08575 | 1/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | BCL2 | P10415 | 1/20 | 0.34 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.34 |
| ▸ | CA4 | P22748 | 1/20 | 0.34 |
| ▸ | CA7 | P43166 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | AHR | P35869 | 2/20 | 0.33 |
| ▸ | TGM2 | P21980 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21695235 | 0.80 | S100A4 (0.41) | S100A4PTPRCCYP2A6CA1CA2 | |
| SCHEMBL22947461 | 0.78 | PTPRC (0.44) | S100A4PTPRCCYP2A6CA1CA2 | |
| SCHEMBL29697204 | 0.75 | S100A4 (0.46) | S100A4PTPRCCA1CA2BCL2 | |
| SCHEMBL1798819 | 0.75 | S100A4 (0.46) | S100A4PTPRCCA1CA2BCL2 | |
| SCHEMBL22928723 | 0.75 | PTPRC (0.45) | S100A4PTPRCCYP2A6CA2CA9 | |
| SCHEMBL17322541 | 0.72 | GPR3 (0.64) | PTPRCCA9MAPK1TDP1L3MBTL1 | |
| SCHEMBL30481783 | 0.72 | GPR3 (0.64) | PTPRCCA9MAPK1TDP1L3MBTL1 | |
| SCHEMBL26017216 | 0.69 | PTPRC (0.40) | S100A4PTPRCCYP2A6CA2CA9 | |
| SCHEMBL16096965 | 0.69 | CA1 (0.43) | S100A4PTPRCCA1CA2BCL2 | |
| SCHEMBL21832064 | 0.69 | S100A4 (0.40) | S100A4PTPRCCA1CA2BCL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11877508-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2024-01-16 | — | — | US | disclosed |
| US-20230200214-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-06-22 | — | — | US | disclosed |
| US-20230189636-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230189636-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | EMC1, EMC2, EPCAM | S100A4 1041/4885PTPRC 741/4885CYP2A6 2104/4885 |
| US-20230200214-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | EMC1, EMC2, EPCAM | S100A4 1041/4885PTPRC 741/4885CYP2A6 2104/4885 |
| US-11877508-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | EMC1, EMC2, EPCAM | S100A4 1041/4885PTPRC 741/4885CYP2A6 2104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.